Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · IEX Real-Time Price · USD
0.710
-0.020 (-2.75%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Quoin Pharmaceuticals Stock Forecast
QNRX's stock price has decreased by -87.87% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for QNRX stock has a target of 4.00, which predicts an increase of 463.46% from the current stock price of 0.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 15, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for QNRX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $15 → $4 | Strong Buy | Maintains | $15 → $4 | +463.46% | Mar 15, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $240 | Strong Buy | Initiates | $240 | +33,707.58% | Sep 7, 2022 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +42,159.47% | May 6, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $750 | Strong Buy | Initiates | $750 | +105,548.68% | Jan 7, 2022 |
| JMP Securities | JMP Securities | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 15, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.96
EPS Next Year
-1.28
from -1.96
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 16.5M | 116.6M | 100.8M |
| Avg | n/a | n/a | 16.0M | 87.4M | 98.0M |
| Low | n/a | n/a | 15.4M | 59.2M | 94.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 626.8% | 15.3% |
| Avg | - | - | - | 444.9% | 12.0% |
| Low | - | - | - | 268.7% | 7.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.79 | -1.31 | -0.07 |
| Avg | -1.96 | -1.28 | -0.07 |
| Low | -2.11 | -1.23 | -0.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.